SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

COLINZ LABORATORIES

BSE: 531210 29 Jun 2025
Healthcare
₹ 49.16
Colinz Laboratories ltd. specializes in Pharmaceuticals within the Healthcare sector.

COLINZ LABORATORIES - Share Price & Details

Market Cap
₹20.7
High /Low
88.7 / 42.0
Stock P/E
41.5
Book Value
₹20.7
Dividend Yield
0.0
ROCE
6.72
ROE
₹5.43
Face Value
10.0
PEG Ratio
1.34
EVEBITDA
₹20.0
Debt
0.64
CMP / FCF
-224.0
Debt to equity
₹0.07
NP Ann
0.50
High price all time
88.7
Piotroski score
₹3.0
Graham Number
22.6
No. Eq. Shares
0.46
Net CF
₹-1.45
Net profit
0.50
Price to book value
2.19
Interest Coverage
₹16.5
Low price all time
2.9
Industry PE
32.7
Reserves
₹6.96
Free Cash Flow
₹-1.71

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
COLINZ LABORATORIES LTD.NANANANA20.741.5
CHEMO PHARMA LABORATORIES LTD.NANANANA17.351.0
Vanta Bioscience LimitedNANANANA17.2

Peer Comparison Chart


About COLINZ LABORATORIES

Colinz Laboratories ltd., with Security Code 531210, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Colinz Laboratories Faces Significant Selling Pressure Amid Market Sentiment Shift

(04 Jun 2025)
Colinz Laboratories Ltd is experiencing notable selling pressure, with today's trading reflecting a decline after two days of gains.
Read more →

Colinz Laboratories Adjusts Valuation Amid Shifting Market Sentiment and Financial Metrics

(21 May 2025)
Colinz Laboratories, a microcap in the Pharmaceuticals & Biotechnology sector, has recently experienced a valuation adjustment reflecting its financial...
Read more →

Colinz Laboratories Adjusts Valuation Grade Amid Competitive Pharmaceutical Landscape

(21 May 2025)
Colinz Laboratories has adjusted its valuation, revealing a price-to-earnings ratio of 26.05 and a price-to-book value of 2.79.
Read more →

Q4 results today: BHEL, Hyundai Motor समेत आज 107 कंपनियां जारी करेंगी अपने तिमाही नतीजे, देखें लिस्ट

(18 May 2025)
Q4 Results Today, May 16: BHEL, Hyundai Motor, Delhivery और Emami सहित 117 कंपनियाँ आज Q4 FY25 के नतीजे जारी करेंगी। जानें किन कंपनियों के प्रदर्शन पर रहेगी बाजार की...
Read more →

Colinz Laboratories standalone net profit rises 7.14% in the March 2025 quarter

(17 May 2025)
Sales decline 11.04% to Rs 1.45 crore. Net profit of Colinz Laboratories rose 7.14% to Rs 0.15 crore in the quarter ended March 2025 as against Rs 0.14...
Read more →

Q4 Results 2025 Today: BHEL, Hyundai Motor India, Shipping Corporation Among 100+ Firms To Declare Earnings

(16 May 2025)
105 companies, including Hyundai Motor India, Shipping Corporation of India, Delhivery, and Reliance Infrastructure, are set to share their...
Read more →